Maria J. Baptista

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

Journal: Blood advances
Published: February 10, 2025

Subtyping Burkitt Lymphoma by DNA Methylation.

Subtyping Burkitt Lymphoma by DNA Methylation.

Journal: Genes, chromosomes & cancer
Published: February 06, 2025

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Journal: Blood advances
Published: November 29, 2022

Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.

Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.

Journal: Histopathology
Published: February 21, 2022

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.

Journal: Blood advances
Published: December 29, 2021

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.

Journal: British journal of haematology
Published: June 22, 2021

Genetic and phenotypic attributes of splenic marginal zone lymphoma.

Genetic and phenotypic attributes of splenic marginal zone lymphoma.

Journal: Blood
Published: May 10, 2021

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 18, 2020

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL.

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL.

Journal: Blood
Published: November 23, 2020

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma.

Journal: Nature communications
Published: September 21, 2020

Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.

Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.

Journal: Histopathology
Published: September 13, 2020

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.

Journal: Hematological oncology
Published: January 31, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026